National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Nat Genet. 2010 Aug;42(8):676-83. doi: 10.1038/ng.629. Epub 2010 Jul 25.
Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation. Here we show that the membrane protease matriptase initiates Netherton syndrome in a LEKTI-deficient mouse model by premature activation of a pro-kallikrein cascade. Auto-activation of pro-inflammatory pro-kallikrein-related peptidases that are associated with stratum corneum detachment was either low or undetectable, but they were efficiently activated by matriptase. Ablation of matriptase from LEKTI-deficient mice dampened inflammation, eliminated aberrant protease activity, prevented detachment of the stratum corneum, and improved the barrier function of the epidermis. These results uncover a pathogenic matriptase-pro-kallikrein pathway that could operate in several human skin and inflammatory diseases.
丝氨酸蛋白酶抑制剂 LEKTI 的缺乏是 Netherton 综合征的病因,它导致角质层分离和慢性炎症。在这里,我们表明膜蛋白酶 matriptase 通过过早激活激肽释放酶原级联反应,在 LEKTI 缺乏的小鼠模型中引发 Netherton 综合征。与角质层分离相关的促炎症性激肽释放酶原相关肽酶的自动激活要么很低或无法检测到,但它们可以被 matriptase 有效激活。从 LEKTI 缺乏的小鼠中剔除 matriptase 可减轻炎症,消除异常的蛋白酶活性,防止角质层分离,并改善表皮的屏障功能。这些结果揭示了一种可能在几种人类皮肤和炎症性疾病中起作用的致病 matriptase-激肽释放酶途径。